Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The comic follows two parallel stories. Hush - a timid mute girl wakes up in a jail cell. Desperate to escape, she befriends another prisoner, Mono, who understands this world far better than her, ...

A good sum of two good parts. Our research team assigns Gold ratings to strategies that they have the most conviction will outperform their Morningstar Category average over a market cycle on a ...

THAT selection in relation to sex has been an important factor in the formation of the present breeds of animals was more than indicated in the “Origin of Species,“and the theory has since been ...